The sobering truth is that 90 percent of all drug possibilities fail. The few that do succeed take an average of 10 years to reach the market and cost anywhere from $2.5 billion to $12 billion to get there.
Covid-19 is uniting the global scientific community with its urgency, prompting scientists to cast aside nation-specific territorialism, research secrecy, and academic publishing politics in favour of expedited therapeutic and vaccine development efforts.
Riding the convergence of massive datasets, skyrocketing computational power and remarkable innovations in AI, we are not far from a world in which personalized drugs, delivered directly to specified targets, will graduate to the standard of care.
MORE